Forte Biosciences (FBRX) Depreciation and Depletion (2016 - 2026)
Forte Biosciences' (FBRX) quarterly Depreciation and Depletion came in at $19000.0 in Q1 2026, up 46.15% year-on-year from $13000.0 in Q1 2025, and little changed on a QoQ basis from $19000.0 in Q4 2025.
Forte Biosciences (FBRX) Depreciation and Depletion (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 10 years of Depreciation and Depletion data on file, last reported at $19000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion rose 46.15% year-over-year to $19000.0 in Q1 2026; TTM through Mar 2026 was $70000.0, a 62.79% increase from a year earlier, with the FY2025 full-year figure at $64000.0, up 64.1% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $19000.0, roughly flat from $19000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for FBRX reached as high as $19000.0 in Q4 2025 and fell as low as $6000.0 in Q4 2023.
- Historically, Depreciation and Depletion has averaged $12800.0 across 4 years, with a median of $11500.0 in 2024.
- On a YoY basis, Depreciation and Depletion climbed as much as 90.0% in 2025 and fell as far as 44.44% in 2025.
- Year by year, Depreciation and Depletion stood at $6000.0 in 2023, then surged by 66.67% to $10000.0 in 2024, then soared by 90.0% to $19000.0 in 2025, then changed by 0.0% to $19000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $19000.0 in Q1 2026, $19000.0 in Q4 2025, and $17000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | 19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,000.00 |
| Mar 31, 2026 | 19,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |